* Surmodics Inc SRDX.OQ reported quarterly adjusted
earnings of
52 cents per share for the quarter ended in June. The mean
expectation of four analysts for the quarter was for earnings of
5 cents per share.
* Revenue rose 111.2% to $52.48 million from a year ago;
analysts
expected $38.06 million.
* Surmodics Inc's reported EPS for the quarter was 52
cents.
* The mean earnings estimate of analysts had risen by
about 110.7%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Surmodics Inc shares had fallen by 0.4% this quarter and
lost 8.6% so far this year.
* The company reported quarterly net income of $7.35
million.
* Wall Street's median 12-month price target for Surmodics
Inc is
$54.00
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 2 at 01:33 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 0.05 0.52 Beat
Mar. 31 2023 -0.51 -0.40 Beat
Dec. 31 2022 -0.66 -0.50 Beat
Sep. 30 2022 -0.45 -0.26 Beat